+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Prevalence and clinical course of olfactory hallucinations in idiopathic Parkinson's disease



Prevalence and clinical course of olfactory hallucinations in idiopathic Parkinson's disease



Journal of Parkinson's Disease 2(3): 199-205



Olfactory hallucinations are known to occur in idiopathic Parkinson's disease (IPD) but are much less well-described than visual hallucinations. To report the prevalence, clinical features, response to treatment and prognosis of olfactory hallucinations in IPD. 205 consecutively reviewed IPD patients and 205 non-IPD control patients attending the local hospital were surveyed for the presence of olfactory hallucinations by specific questioning; the IPD patients were followed up for at least three years. Of 188 patients who had a clinical course remaining consistent with IPD, four were initially found to have olfactory hallucinations, yielding a prevalence of 2.1% (95% confidence interval 0.4-5.4%). Two further patients developed such hallucinations later during the study. Olfactory hallucinations were not always accompanied by other hallucination modalities. The patients had a long duration of disease treated with dopaminergic medication, loss of sense of smell typical for IPD, no dementia or features suggestive of non-idiopathic PD after three years follow-up, a lack of insight into their hallucinations with consequent failure to report them spontaneously, and a good and lasting response to modest doses of atypical antipsychotics. This study confirms the significant prevalence of olfactory hallucinations, describes their clinical features and indicates that they may occur in isolation and not predict other psychotic or dementing features. The nuisance that such hallucinations cause, their ease of treatment and their failure to be volunteered as a symptom means that specific questioning for their presence should be included in routine assessment of patients with IPD.

(PDF emailed within 0-6 h: $19.90)

Accession: 055149263

Download citation: RISBibTeXText

PMID: 23938227

DOI: 10.3233/JPD-2012-012086


Related references

Prevalence and phenomenology of olfactory hallucinations in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry 83(10): 1019-1021, 2012

Relationship of olfactory function with olfactory bulbus volume, disease duration and Unified Parkinson's disease rating scale scores in patients with early stage of idiopathic Parkinson's disease. Journal of Clinical Neuroscience 20(10): 1469-1470, 2014

Olfactory hallucinations in Parkinson's disease. South African Medical Journal 60(25): 950-950, 1981

The relationship between clinical severity and olfactory bulb volume in idiopathic Parkinson's disease. Journal of the Neurological Sciences 357: E263-E264, 2015

Olfactory and visual hallucinations in Parkinson's disease. Parkinsonism & Related Disorders 10(4): 253-254, 2004

Prevalence of radiological and clinical cerebrovascular disease in idiopathic Parkinson's disease. Clinical Neurology and Neurosurgery 113(10): 830-834, 2012

Comprehensive identification of delusions and olfactory, tactile, gustatory, and minor hallucinations in Parkinson's disease psychosis. Parkinsonism & Related Disorders, 2018

Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study. Lancet. Neurology 4(10): 605-610, 2005

Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain 123: 733-745, 2000

Fifty Percent Prevalence of Extracampine Hallucinations in Parkinson's Disease Patients. Frontiers in Neurology 6: 263-263, 2016

Prevalence and risk factors for visual hallucinations in Chinese patients with Parkinson's disease. Journal of the Neurological Sciences (): -, 2016

Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson's disease. Pharmacogenetics 10(1): 43-48, 2000

Olfactory pathogenesis of idiopathic Parkinson disease revisited. Movement Disorders 23(8): 1076-1084, 2008

Olfactory loss may be a first sign of idiopathic Parkinson's disease. Movement Disorders 22(6): 839-842, 2007

Olfactory function in patients with idiopathic Parkinson's disease. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 50(1): 20-24, 2015